Danaher Announces Appointments of Daniel Comas and Robert Hershberg to Board of Directors
Danaher appointed Daniel Comas, a former EVP and CFO of the company, and Robert Hershberg, a biopharma executive and former Celgene CSO, to its board effective October 9, 2026. The board expanded from 11 to 13 directors, while Alan Spoon will retire at the 2027 annual meeting rather than stand for reelection.
Key figures
- Board size after
- 13
- Board size before
- 11
- Rsu waived by co founders each
- 500000
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.